SARA NEWMAN: Open Payments
NPI 1679260715 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 13 payments from 10 companies in 2025. Trend: 2023 $776 · 2024 $2,817 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $244 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Genentech, Inc. | 1 | $98 |
| Alexion Pharmaceuticals, Inc. | 1 | $69 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $32 |
| Genentech USA, Inc. | 1 | $28 |
| Biogen, Inc. | 1 | $21 |
| Merz Pharmaceuticals, LLC | 1 | $18 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, ZEPOSIA, Ocrevus, ULTOMIRIS, Symbravo, NURTEC ODT, Ocrevus Zunovo, VUMERITY.
Industry payments across SD — which companies pay providers there.
